These sRNAs were chosen because microarray analysis showed that their amounts in the tumor cells were high relative to the other transferred sRNAs, and also because their reported gene targets may be of relevance for a protective role, for example in apoptosis, in cell cycle, or in p53 signaling. This evidence concerns the gene TP53 and neoplasm.